ATAGI have now recommended COVID-19 vaccination for some children aged 6 months – 5 years. Eligible groups include those with severe immunocompromise, a disability with severe or complex health needs, or those with multiple/complex health conditions that increase the risk of severe COVID-19 disease.
A paediatric formula of the Moderna COVID-19 vaccine has been approved by the TGA in this age group for children in the groups mentioned above. A primary two-dose schedule, 8 weeks apart is recommended, with the dose being 25mcg. Children in this age group with severe immunocompromise are recommended to complete a 3-dose primary schedule.
ATAGI does not currently recommend COVID vaccination for children aged 6 months – 5 years who are not in the categories previously mentioned, based on a range of factors.
Recommendations may change as alternative brands or variant COVID-19 vaccines become available in this age group, or if there are epidemiological changes such as new variants of concern that emerge.
To read the recommendations in full please follow the link below.
ATAGI recommendations on COVID-19 vaccine use in children aged 6 months to <5 years